Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources— Press Trust of India (@PTI_News) May 11, 2021
Bharat Biotech's COVID-19 vaccine Covaxin recommended by expert panel for phase II/III clinical trials on 2 to 18 year-olds: Sources